Interleukin-6 and tumor necrosis factor-α levels increase in response to maximal exercise in patients with chronic heart failure

International Journal of Cardiology

Volumn 87, Issue 1, 2003, Pages 83-90

  Kinugawa, Toru ^a   Kato, Masahiko ^a   Ogino, Kazuhide ^a   Osaki, Shuichi ^a   Tomikura, Yoko ^a   Igawa, Osamu ^a   Hisatome, Ichiro ^a   Shigemasa, Chiaki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Catecholamines; Cytokine; Exercise; Heart failure

Indexed keywords

ADRENALIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CATECHOLAMINE; CYTOKINE; INTERLEUKIN 6; NEUROHORMONE; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DYNAMIC EXERCISE; EXERCISE TEST; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NORADRENALIN BLOOD LEVEL; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REST;

ATRIAL NATRIURETIC FACTOR; CASE-CONTROL STUDIES; CHRONIC DISEASE; EPINEPHRINE; EXERCISE TEST; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INTERLEUKIN-6; LINEAR MODELS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NOREPINEPHRINE; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037212713     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00200-0     Document Type: Article

References (44)

1. Turnbull A.V., Rivier C.L. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines; actions and mechanisms of action. Physiol Rev. 79:1999;1-71.
2. Vassali P. The pathophysiology of tumor necrosis factor. Annu Rev Immunol. 10:1992;411-452.
3. Papanicolaou D.A., Wilder R.L., Monolagas S.C., Chrousos G.P. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 128:1998;127-137.
4. Levine B., Kalman J., Mayer L., Fillit H.M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. New Engl J Med. 323:1999;236-241.
5. Aukrust P., Ueland T., Lien E., et al. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 83:1999;376-382.
6. Torre-Amione G., Kapadia S., Benedict C., Oral H., Young J.B., Mann D.L. Proinflammatory cytokine levels in patients with depressed left ventricular dysfunction. J Am Coll Cardiol. 27:1996;1201-1206.
7. Munger M.A., Johnson B., Amber I.J., Callahan K.S., Gilbert E.W. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am Heart J. 77:1996;723-727.
8. Tsutamoto T., Hisanaga T., Wada A., et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol. 31:1998;391-398.
9. Anker S.D., Chua T.P., Ponikowski P., et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation. 96:1997;526-534.
10. Mann D.L. Recent insights into the role of tumor necrosis factor in the failing heart. Heart Fail Rev. 6:2000;71-80.
11. Wollert K.C., Drexler H. The role of interleukin-6 in the failing heart. Heart Fail Rev. 6:2001;95-103.
12. Feldman A.M., Combes A., Wagner D., et al. The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol. 35:2000;537-544.
13. Moldoveanu A.I., Shephard R.J., Shek P.N. The cytokine response to physical activity and training. Sports Med. 31:2001;115-144.
14. Pedersen D.K., Hoffman-Goetz L. Exercise and the immune system: Regulation, integration, and adaptation. Physiol Rev. 80:2000;1055-1081.
15. Adamopoulos S., Parissis J., Kroupis C., et al. Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. Eur Heart J. 22:2001;791-797.
16. Adamopoulos S., Parissis J., Karatzas D., et al. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure. J Am Coll Cardiol. 39:2002;653-663.
17. Teichholz L.E., Kreulen T., Herman M.V., Gorlin R. Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol. 37:1976;7-11.
18. Isomura M., Ueno M., Shimada K., Kogaki H., Ashihara Y. Highly sensitive chemiluminescent enzyme immunoassay with gelatin-coated ferrite solid phase. Clin Chem. 40:1994;1830-1831.
19. Ohkura Y., Nohta H. Fluorogenic reagents for the derivatization of catecholamines and related compounds for liquid chromatographic analysis of biological samples. Trends Anal Chem. 11:1992;74-79.
20. Mukoyama M., Nakao K., Hosoda K., et al. Brain natriuretic peptide (BNP) as a novel cardiac hormone in humans: Evidence for an exquisite dual natriuretic peptide system ANP and BNP. J Clin Invest. 87:1991;1402-1412.
21. Kinugawa T., Ogino K., Noguchi N., et al. Sympathetic nervous response relative to the adenosine triphosphate supply-demand imbalance during exercise is augmented in patients with heart failure. Chest. 114:1998;1295-1300.
22. Sue D.Y., Wasserman K., Morrica R.B., Casaburi R. Measurement of anaerobic threshold by V-slope method in patients with chronic obstructive lung disease and normal subjects. Chest. 94:1988;931-938.
23. Raymond R.J., Dehmer G.J., Theoharides T.C., Deliargyris E.N. Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction. Am Heart J. 141:2001;435-438.
24. Cicoira M., Bolger A.P., Doehner W., et al. High tumor necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients. Cytokines. 15:2001;80-86.
25. Ostrowski K., Rohde T., Asp S., Schjerling P., Pedersen B.K. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol (Lond). 515:1999;287-291.
26. Brenner I.K.M., Natale V.M., Vasiliou P., Moldoveanu A.I., Shek P.N., Shephard R.J. Impact of three different types of exercise on components of the inflammatory response. Eur J Appl Physiol. 80:1999;452-460.
27. Moldoveanu A.I., Shephard R.J., Shek P.N. Prolonged exercise elevates plasma levels but not gene expression of IL-1β, IL-6, and TNF-α in circulating mononuclear cells. J Appl Physiol. 89:2000;1499-1504.
28. Rivier A., Pene J., Chanez P., et al. Release of cytokines by blood monocytes during strenuous exercise. Int J Sports Med. 15:1994;192-198.
29. Bruunsgaard H., Galbo H., Halkjaer K.J., Johansen T.L., Maclean D.A., Pedersen B.K. Exercise-induced increase in interleukin-6 is related to muscle damage. J Physiol (Lond). 499:1997;833-841.
30. Ostrowski K., Hermann C., Bangash A., Schjerling P., Nielsen J.N., Pedersen B.K. A trauma-like elevation of plasma cytokines in humans in response to treadmill running. J Physiol (Lond). 513:1998;889-894.
31. Ostrowski K., Rohde T., Asp S., Schjerling P., Pedersen B.K. The cytokine balance and strenuous exercise: TNF-alpha, IL-2beta, IL-6, IL-1ra, sTNF-r1, sTNF-r2, and IL-10. J Physiol (Lond). 515:1999;287-291.
32. Tsigos C., Papanicolaou D.A., Kyrou I., Deffensor R., Mitsiadis C.S., Chrousos G.P. Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab. 82:1997;4167-4170.
33. Stouthard J.M., Romijn J.A., van der Pol T., et al. Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol. 268:1995;E813-E819.
34. Bozkurt B., Torre-Amione G., Warren M.S., et al. Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation. 103:2001;1044-1047.
35. Papanicolaou D.A., Petrides J.S., Tsigos C., et al. Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol. 271:1996;E601-E605.
36. DeRijk R.H., Boelen A., Tilders F.J.H., Berkenbosch F. Induction of plasma interleukin-6 by circulating adrenaline in the rat. Psychoneuroendocrinology. 19:1994;155-163.
37. Van Gool J., Van Vugt H., Helle M., Aarden L.A. The relation among stress, adrenaline, interleukin 6 and acute phase proteins in the rat. Clin Immunol Immunopathol. 57:1990;200-210.
38. Søndergaard S.R., Ostrowski K., Ullum H., Pedersen B.K. Changes in plasma concentrations of interleukin-6 and interleukin-1 receptor antagonists in response to adrenaline infusion in humans. Eur J Appl Physiol. 83:2001;95-98.
39. Steensberg A., van Hall G., Osada T., Sacchetti M., Saltin B., Pedersen B.K. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol (Lond). 529:2000;237-242.
40. Keller N., Larsen J., Sykulski R., Storm T., Thamesborg G. Atrial natriuretic factor during exercise in patients with congestive heart failure. Acta Endocrinol (Copenh). 118:1988;168-172.
41. Kapadia S.R., Oral H., Lee J., Nakano M., Taffet G.E., Mann D.L. Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. Circ Res. 81:1997;187-195.
42. Palmieri E.A., Benincasa G., Di Rella F., et al. Differential expression of TNF-α, IL-6, and IGF-1 by graded mechanical stress in normal rat myocardium. Am J Physiol. 282:2002;H926-H934.
43. Ogawa H., Nakao K., Mukoyama M., et al. Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricule is a major site of synthesis and secretion of brain natriuretic peptide. Circ Res. 69:1991;491-500.
44. Hasegawa K., Fujiwara H., Itoh H., et al. Light and electron microscopic localization of brain natriuretic peptide in relation to atrial natriuretic peptide in porcine atrium: immunohistocytochemical study using specific monoclonal antibodies. Circulation. 84:1991;1203-1209.